Search

Your search keyword '"T cells -- Health aspects"' showing total 115 results

Search Constraints

Start Over You searched for: Descriptor "T cells -- Health aspects" Remove constraint Descriptor: "T cells -- Health aspects" Publisher states news service Remove constraint Publisher: states news service
115 results on '"T cells -- Health aspects"'

Search Results

1. RISK OF SECONDARY CANCERS AFTER CAR T THERAPY MAY BE SIMILAR TO RISK AFTER OTHER CANCER TREATMENTS

2. OLD CHEMO DRUG, NEW PANCREATIC CANCER THERAPY?

3. LEANING INTO THE IMMUNE SYSTEM'S COMPLEXITY

4. HIV TRIGGERS BODY'S OWN INFLAMMATORY PATHWAYS TO KILL T CELLS

6. IMMUNE CELLS BECOME EXHAUSTED WITHIN HOURS OF ENCOUNTERING TUMORS

7. MICE WITHOUT IMMUNE CELLS SHOW NO SARS-COV-2 SYMPTOMS

8. SCIENTISTS ENGINEER POTENT IMMUNE CELLS FOR 'OFF-THE-SHELF' CANCER IMMUNOTHERAPY

9. RESEARCHERS AT UMASS AMHERST SHOW HOW A SMALL STRAND OF RNA IS KEY TO FIGHTING CANCER

10. $3.4M GRANT TO TACKLE 'BIGGEST CHALLENGE' TO HIV CURE

11. CAR T-CELL THERAPY CHANGES DYNAMIC IN FIGHT AGAINST SOME CANCERS

12. T-CELL VACCINE FOR COVID-19 MAY LAST LONGER THAN CURRENT VACCINES

13. SARS-COV-2 INFECTION WEAKENS IMMUNE-CELL RESPONSE TO VACCINATION NIH-FUNDED STUDY SUGGESTS NEED TO BOOST CD8+ T CELL RESPONSE AFTER INFECTION

14. RESEARCHERS IDENTIFY KEY SOURCE OF T CELL 'EXHAUSTION'

15. NEW TECHNOLOGY SHOWS PROMISE FOR SAFER CANCER THERAPY

16. WORLD-FIRST USE OF BASE-EDITED CELLS TO TREAT 'INCURABLE' LEUKAEMIA

17. PFIZER AND BIONTECH ADVANCE NEXT-GENERATION COVID-19 VACCINE STRATEGY WITH STUDY START OF CANDIDATE AIMED AT ENHANCING BREADTH OF T CELL RESPONSES AND DURATION OF PROTECTION

18. THERAPEUTIC HIV VACCINE WITH OXFORD TECHNOLOGY ACHIEVES ENCOURAGING RESULTS

19. NOVAVAX COVID-19-INFLUENZA COMBINATION VACCINE CANDIDATE INDUCED ANTIBODY AND T-CELL RESPONSES AGAINST SARS-COV-2 AND HOMOLOGOUS AND HETEROLOGOUS INFLUENZA STR

20. HOW THE THYMUS TRAINS T CELLS TO FIGHT INFECTIONS

21. COVAXIN CAN HELP IN CONTROLLING THE VIRUS LOAD OF SARS-COV-2 AND ITS VARIANTS, REDUCING DISEASE SEVERITY: STUDY

22. T CELLS PROTECT AGAINST COVID-19 IN ABSENCE OF ANTIBODY RESPONSE

23. MAYO CLINIC RESEARCHERS LOAD CAR-T CELLS WITH ONCOLYTIC VIRUS TO TREAT SOLID CANCER TUMORS

24. NEW TOOL REVEALS HOW IMMUNE CELLS FIND THEIR TARGETS

25. BLOOD TEST FIGURES IN CANCER RISK FOR PEOPLE WITH HIV

26. COVID-19 IMMUNE RESPONSE IMPROVES FOR MONTHS AFTER VACCINATION

27. SCIENTISTS REVEAL HOW SLEEPING IMMUNE CELLS 'WAKE' TO CONFRONT FAMILIAR FOES

28. IT'S WHAT'S ON THE OUTSIDE THAT COUNTS

29. MOST PEOPLE WITH PRIOR SARS-COV-2 INFECTION OR VACCINATION HAVE T CELL IMMUNE RESPONSES AGAINST OMICRON VARIANT DESPITE LOW ANTIBODY RESPONSES

30. INOVIO ANNOUNCES STRATEGY TO ADDRESS OMICRON (B.1.1.529) AND FUTURE SARS-COV-2 VARIANTS

31. A NEW CLASS OF CAR T CELLS TARGETS PREVIOUSLY UNTARGETABLE CANCER DRIVERS

32. NEW APPROACHES TO THE DEVELOPMENT AND EVALUATION OF VACCINES AGAINST HEPATITIS VIRUSES

33. STUDY PREDICTS WHO MAY BENEFIT FROM CAR-T CELL THERAPY FOR BLOOD CANCERS

34. MODERNA ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 STUDY OF ITS IL-2 MRNA THERAPEUTIC

35. STUDIES UNCOVER DETAILS OF 'EXHAUSTED' IMMUNE CELLS IN PATIENTS WITH CHRONIC INFECTIONS

36. SEN. MARSHALL: ADVANCING T-CELL TESTING CAN HELP PARENTS MAKE INFORMED DECISIONS ON COVID VACCINATIONS

37. LATEST DATA ON IMMUNE RESPONSE TO COVID-19 REINFORCES NEED FOR VACCINATION, SAYS OXFORD-LED STUDY

39. A TRAIT OF THE RARE FEW WHOSE BODIES NATURALLY CONTROL HIV: 'TRAINED' IMMUNE CELLS

40. PENN MEDICINE CANCER CELL THERAPY PIONEER CARL JUNE, MD, RECEIVES THE SANFORD LORRAINE CROSS AWARD

41. ANTIBODIES AND T CELLS PROTECT AGAINST SARS-COV-2

42. ON B AND T LYMPHOCYTES

43. NOVEL DUAL CAR T CELL IMMUNOTHERAPY HOLDS PROMISE FOR TARGETING THE HIV RESERVOIR

44. O'HALLERAN, MARSHALL, DELBENE, AND BUCSHON SECURE MEDICARE PAYMENTS FOR INNOVATIVE CANCER THERAPIES

45. MARSHALL, DELBENE, BUCSHON, AND O'HALLERAN APPLAUD CMS FOR SECURING MEDICARE PAYMENTS ON INNOVATIVE CANCER THERAPIES

46. DELBENE, MARSHALL, BUCSHON, AND O'HALLERAN APPLAUD CMS FOR SECURING MEDICARE PAYMENTS ON INNOVATIVE CANCER THERAPIES

47. PERSISTENT IMMUNE MEMORY OF COVID-19 FOUND IN RECOVERED PATIENT T CELLS

48. LOCKING DOWN SHAPE-SHIFTING SPIKE PROTEIN AIDS DEVELOPMENT OF COVID-19 VACCINE

49. NEW STUDY REVEALS OXFORD CORONAVIRUS VACCINE PRODUCES STRONG IMMUNE RESPONSE

50. OXFORD IMMUNOTEC RELEASES T-SPOT DISCOVERY SARS-COV-2 KIT

Catalog

Books, media, physical & digital resources